<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Medical devices are of increasing importance in <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> and have made important contributions to patient care </plain></SENT>
<SENT sid="1" pm="."><plain>These devices continue to evolve with increasing complexity </plain></SENT>
<SENT sid="2" pm="."><plain>FDA regulation of medical devices involves increased stringency for higher risk and novel devices </plain></SENT>
<SENT sid="3" pm="."><plain>However, there are some current opportunities to strengthen the FDA's pre-approval regulatory process and improve post-marketing surveillance </plain></SENT>
<SENT sid="4" pm="."><plain>This article reviews FDA regulation of cardiovascular devices and offers suggestions for strengthening the process while focusing on examples relevant to cardiac electrophysiologists </plain></SENT>
</text></document>